APYX Reports New Study Showing 81.8% Improvement in Cellulite Appearance with Avéli and Renuvion Treatment, Demonstrating Measurable Reductions in Dimple Volume and Increased Collagen/Elastin
Apyx Medical Corporation Common Stock · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · Now $3.96
-8.2% in 3d after detection
Post-detection moves
1h
—
1d
-2.8%
3d
-8.2%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS